Evaluating the antioxidative activity of diselenide containing compounds in human blood

• This study determine the antioxidant effects of synthetic organoselenium compounds.
• Diselenides protect platelets and plasma against toxic action of ONOO− and Fe2+.
• In experimental trials tested compounds decreased levels oxidative stress markers.
• Compounds with an aromatic ring are better antioxidant than ebselen.

This study was designed to determine and compare the antioxidant effects of synthetic organoselenium compounds. In experimental trials three different diselenides were used: bis(2-hydroxyphenyl) diselenide, bis{[2-(4-hydroxybenzyl)imino]phenyl} diselenide and bis[2-(4-methylphenylsulfonylamino)phenyl] diselenide. The compounds were screened for antioxidant activities in human blood under oxidation stress conditions. Oxidative stress was induced in vitro in human blood platelet samples and in plasma by 0.1 mM peroxynitrite (ONOO−) or by Fe2+. In experimental trials the levels of chosen oxidative stress markers (TBARS, O2-, and protein carbonyl groups) were significantly decreased by the action of the tested compounds. The antioxidative properties and the changes in proteins and lipids in the presence of new synthesized selenoorganic compounds were studied in vitro and compared with activity of ebselen (2-phenyl-1,2-benzisoselenazol-3(2H)-one) – a classical antioxidant, well known as the most important glutathione peroxidase mimetic agent. Our results indicate that the tested diselenides have distinctly protective effects against oxidative alterations of biomolecules caused by ONOO− and Fe2+ in blood platelets and in plasma. Therefore it seems that not only ebselen with a wide spectrum of therapeutic actions but also other organoselenium compounds can be considered in the future as active pharmacological agents.

Figure optionsDownload as PowerPoint slide